Evidence map›Paper›PMID 20876743›Full record

ArticleMolecular pharmacology2011

Diclofenac distinguishes among homomeric and heteromeric potassium channels composed of KCNQ4 and KCNQ5 subunits.

Lioubov I Brueggemann, Alexander R Mackie, Jody L Martin, Leanne L Cribbs, Kenneth L Byron

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Molecular pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. KCNQ5 activation by tannins mediates vasorelaxant effects of barks used in Native American botanical medicine.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  4. Article
  5. Article
  6. Chemical modulation of Kv7 potassium channels.RSC medicinal chemistry · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Pirfenidone Is a Vasodilator: Involvement of KFrontiers in pharmacology · 2020
    Article
  12. Article
  13. Article
  14. Selective activation of vascular KBritish journal of pharmacology · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lioubov I BrueggemannDepartment of Molecular Pharmacology and Therapeutics, Loyola University Medical Center,Maywood, IL 60153, USA.
Alexander R Mackie
Jody L Martin
Leanne L Cribbs
Kenneth L Byron
Loyola University Chicago · USLoyola University Medical Center · US

Funding

KCNQ Channels and Vasoconstrictor Signal TransductionR01HL089564 · NHLBI · LOYOLA UNIVERSITY CHICAGO · PI BYRON, KENNETH L · 2009 to 2013
$1.9M
NHLBI NIH HHS R01 HL089564NHLBI NIH HHS R01-HL089564
6 · The paper itself

Abstract

KCNQ4 and KCNQ5 potassium channel subunits are expressed in vascular smooth muscle cells, although it remains uncertain how these subunits assemble to form functional channels. Using patch-clamp techniques, we compared the electrophysiological characteristics and effects of diclofenac, a known KCNQ channel activator, on human KCNQ4 and KCNQ5 channels expressed individually or together in A7r5 rat aortic smooth muscle cells. The conductance curves of the overexpressed channels were fitted by a single Boltzmann function in each case (V(0.5) values: -31, -44, and -38 mV for KCNQ4, KCNQ5, and KCNQ4/5, respectively). Diclofenac (100 μM) inhibited KCNQ5 channels, reducing maximum conductance by 53%, but increased maximum conductance of KCNQ4 channels by 38%. The opposite effects of diclofenac on KCNQ4 and KCNQ5 could not be attributed to the presence of a basic residue (lysine) in the voltage-sensing domain of KCNQ5, because mutation of this residue to neutral glycine (the residue present in KCNQ4) resulted in a more effective block of the channel. Differences in deactivation rates and distinct voltage-dependent effects of diclofenac on channel activation and deactivation observed with each of the subunit combinations (KCNQ4, KCNQ5, and KCNQ4/5) were used as diagnostic tools to evaluate native KCNQ currents in vascular smooth muscle cells. A7r5 cells express only KCNQ5 channels endogenously, and their responses to diclofenac closely resembled those of the overexpressed KCNQ5 currents. In contrast, mesenteric artery myocytes, which express both KCNQ4 and KCNQ5 channels, displayed whole-cell KCNQ currents with properties and diclofenac responses characteristic of overexpressed heteromeric KCNQ4/5 channels.

Indexed as

Action PotentialsAnimalsCells, CulturedDiclofenacHumansKCNQ Potassium ChannelsMaleMuscle, Smooth, VascularPatch-Clamp TechniquesProtein SubunitsRatsRats, Sprague-DawleyDiclofenacKcnq4 protein, ratKcnq5 protein, ratKCNQ Potassium ChannelsProtein Subunits

Identifiers

PMID20876743
PMCPMC3014280
OpenAlexW2122197498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.